One-strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable. Jutel M, Vogelberg C, Duwensee K, Troyke D, et al. Allergy 2025;80:807-816.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jutel M, Vogelberg C, Duwensee K, Troyke D, et al. One-strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable. Allergy 2025;80:807-816.
PMID: 39540587